Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Leg pain medication may prevent re-blockage of neck arteries after a stent
Categories: Stroke News & Brain Health, Scientific Conferences & Meetings
|
Published: February 21, 2020

Leg pain medication may prevent re-blockage of neck arteries after a stent

American Stroke Association International Stroke Conference – Late Breaking Science News Release (LB 21)
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Hiroshi Yamagami, M.D., Ph.D.,presents LB 21

Hiroshi Yamagami, M.D., Ph.D., presents Cilostazol versus Other Anti-platelet Drugs for the In-stent Restenosis After Carotid Artery Stenting: The Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE) Trial during ME III, Closing Main Event at the American Heart Association / American Stroke Association International Stroke Conference at the Los Angeles Convention Center.

copyright American Heart Association -Photo by Todd Buchanan 2020

Download (2.2 MB)
Hiroshi Yamagami, M.D., Ph.D.,presents LB 21

Hiroshi Yamagami, M.D., Ph.D.,presents LB 21

Hiroshi Yamagami, M.D., Ph.D., presents Cilostazol versus Other Anti-platelet Drugs for the In-stent Restenosis After Carotid Artery Stenting: The Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE) Trial during ME III, Closing Main Event at the American Heart Association / American Stroke Association International Stroke Conference at the Los Angeles Convention Center.

copyright American Heart Association -Photo by Todd Buchanan 2020


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (2.2 MB) File Permalink

Hiroshi Yamagami, M.D., Ph.D.

Hiroshi Yamagami, M.D., Ph.D., director of the Department of Stroke Neurology, National Hospital Organization Osaka National Hospital, Japan

copyright Misato Yasufuku

Download (410.9 kB)
Hiroshi Yamagami, M.D., Ph.D.

Hiroshi Yamagami, M.D., Ph.D.

Hiroshi Yamagami, M.D., Ph.D., director of the Department of Stroke Neurology, National Hospital Organization Osaka National Hospital, Japan

copyright Misato Yasufuku


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (410.9 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Hiroshi Yamagami, M.D., Ph.D.,presents LB 21
  • Hiroshi Yamagami, M.D., Ph.D.
  • ISC Logo

Related Video

Elkind ISC20 perspective on LB 21

Mitchell S. V. Elkind, M.D., M.S., FAHA, FAAN, president elect of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association and professor of neurology and epidemiology at Columbia University New York and attending neurologist at Columbia University Medical Center of the New York-Presbyterian Hospital.

Transcript (txt)

News Release

copyright American Heart Association

Download (243.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Elkind ISC20 perspective on LB 21

Mitchell S. V. Elkind, M.D., M.S., FAHA, FAAN, president elect of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association and professor of neurology and epidemiology at Columbia University New York and attending neurologist at Columbia University Medical Center of the New York-Presbyterian Hospital.

Transcript (txt)

News Release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (243.2 MB) File Permalink
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED